The growing prevalence of diabetes, hypertension and a large susceptible elderly population, are rapidly driving up the number of people developing end stage renal diseases (ESRD) in Nigeria, spurring an upsurge of new investments in dialysis business valued at $314 million (N54 billion).
The numbe
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
Alexander Chiejina
Nigeria's leading finance and market intelligence news report. Also home to expert opinion and commentary on politics, sports, lifestyle, and more
